Myriad Genetics Inc. (NASDAQ:MYGN)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for MYGN
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Louis Berg: $FLGT, $AQUA, $ATKR, $BLD, $IPI, $MYGN, $SNOW, $TA, $TSQ
- Louis Berg: $MYGN...Something is brewing here
- Louis Berg: $MYGN. This one looks really good right here....Check it out.
- DrScience: $NVTA Added shares at the open @ 17.50, and just now STO FEB 20 Calls @ .85. I plan to hold this position over earnings report, tentatively scheduled for 2/18. My sentiment could change should I get a poor read when $MYGN, the lead dog in the pack, reports sometime in the next week. As said before, this is a volatile stock, and the company depends on Medicare for 23% of its revenues. Here are the numbers for those wanting to participate in a FEB 20 Covered Call... NVTA 21-Feb-20 20 Covered Call @ 17.71 with 25 DTE --- Cash Settled Account (IRA) ==================== Buy 100 Shares at $18.51: $1,851.00 Sell 1 $20.00 Strike Call at $0.80: ($80.00) Capital Required: $1,771.00 Cost Basis (Break Even): $17.71 Maximum Gain: $229.00 Return on Investment (ROI): 12.93% Annualized Return: 490.26% Margin Account ==================== Buy 100 Shares at $18.51: $925.50 Sell 1 $20.00 Strike Call at $0.80: ($80.00) Capital Required: $845.50 Possible Cost of Broker Carry at 7.00%: $4.44 Cost Basis (Break Even): $17.75 Maximum Gain: $224.56 Return on Investment (ROI): 26.56% Annualized Return: 3015.41%
- 86944T: $MYGN Just wondering if anyone in the forum follows this stock. Bought it the other day on the oversold bounce, put in a LOD stop and it never took it out, so I still own it with a tighter stop. The last 3 earnings reports, it seems to go off a cliff, then drift up 10 points over the next 3 months until the next earnings call. 10 points on a $24 stock is pretty good. Just looking to see if anyone follows.
- champ: @86944T $MYGN --- Very nice ER miss bounce trade, you explained it perfectly. I never look at this before...nice post.
- barbjim12: @86944T $MYGN I am in this stock just like you. Hope it follows the same move up 10 points. Stop in place also.
- petros06: $MYGN trying to recover
- petros06: @Dan $MYGN up 9.5%. I caught 7% of it. Thx
- DAN: @petros06 $MYGN Nice job!!! Pays to watch a stock that does not rebound on Day 1. ;-)
- djmurph: @petros06 $MYGN Nice work @petros06. I put an order in at 21.40 that didn't get filled, then it felt like I'd be chasing it, then real-job duties called and I'm just now seeing where it's at. Argh.
- Herb: @DAN $MYGN Dang! Lost $ on it yesterday. . . . .
- rverkamp: @petros06 $MYGN $NSP $PLT $ATUS are a few I am stalking for tomorrow
- petros06: @rverkamp $MYGN $NSP $PLT $ATUS thx I'll put them on my list
- 86944T: @petros06 $MYGN Thanks for posting. I bought it near the open, put in a stop and forgot about it. It may wander higher, but after reading your post, I sold for a profit. Thx.
- issues: @petros06 $MYGN Others in the same group are struggling also: $PRAH & $MEDP
- petros06: @rverkamp $MYGN $NSP $PLT $ATUS $PLT on the move
-
DAN: ...
COTD: $MTCH $MYGN 59-minute trades.
$SPX - Resting. Market will need to rest here for a while, or pull back before it can go higher. $Don’t be aggressive, and don’t be early.
$DJI -- same bed as SPX
$NDX - resting
Growth Stocks:
$EDU ... - Herb: @DAN $MTCH $MYGN $SPX $Don $DJI $NDX $EDU $CPRT $PLMR $PAYS $SHAK $OPRX $WBA $VZ $COST $TTC $CHK $MDR $XOM Did you take $MTCH today? If so, at what price and what time did you buy it?
- Wolf: #EARNINGS AMC. VERIFY AS NEWS CAN CHANGE. Ticker Volume M % change Revenue earnings Guidance THOUGHTS $SHAK 0.9 -18 MISS BEAT POSITIVE $AAN 0.8 -5 MISS MISS OK $BKD 1 -5 MISS BIG MISS GOOD $CCXI 0.4 41 BEAT BEAT BIO NEWS Q4 $CPE 18 3 BEAT MISS $CHGG 1.7 10 BEAT BEAT GOOD $FPAY .12 LOW 20 BIG BEAT BIG BEAT UPDATING $FRPT 0.4 1 BEAT BEAT POSITIVE $THC 1.5 5 BEAT BEAT GOOD $UBER 10 -7 MISS IPO $GRPN 5 -10 MISS MISS REITERATE $MDR 18 -15 BIG MISS PIPELINE REMAINS Ok $MYGN 1.2 -30 MISS MISS BAD $MOS 4.8 -5 BAD BAD BAD DIP AND BOUNCE $TNDM 1.2 -10 BEAT BEAT OK BOUNCE $APPS 2 -5 BEAT BEAT STRONG DEMAND RUN UP? $EVER .25 LOW 20 BEAT BEAT GOOD LOW VOLUME $EVBG 0.54 10 BEAT BEAT OK $FRPT 0.4 MISS REAFFIRM BIG MOVER $HTZ 3.4 2 BEAT inline $SNCR 0.45 -15 MISS MISS BOUNCE, SHORT? $RNG 7 BIG BEAT BIG BEAT GOOD RUN UP? $REAL #IPO 1.5 3 BIG BEAT BEAT GOOD RUN UP? #DIOD .44 -10 SLIGHT MISS BEAT BOUNCE
- Tango: @Wolf $SHAK $AAN $BKD $CCXI $CPE $CHGG $FPAY $FRPT $THC $UBER $GRPN $MDR $MYGN $MOS $TNDM $APPS $EVER $EVBG $HTZ $SNCR $RNG $REAL #EARNINGS #IPO #DIOD Thanks!
- greenpatrol: @Wolf $SHAK $AAN $BKD $CCXI $CPE $CHGG $FPAY $FRPT $THC $UBER $GRPN $MDR $MYGN $MOS $TNDM $APPS $EVER $EVBG $HTZ $SNCR $RNG $REAL #EARNINGS #IPO $DIOD Thanks @Wolf!
- DAN: $MYGN $SHAK -- Gap traders might want to watch these two stocks for signs of short covering and an oversold bounce. Don't anticipate it. That's the biggest mistake that I see traders make here. "I bought $XYZ on your recommendation and I'm down 10%. What should I do?" I never "recommend" a stock or option trade based on what I think will happen in the future. My crystal ball is broken. Dan
- DAN: $SHAK $MYGN -- Neither of these stocks are rebounding this morning. Put both of these on your watch list. At some point over the next few days, they are likely to start moving higher after all the "Oh crap! This is a disaster!' selling is done. But it rarely pays to anticipate the rebound.
- DAN: Palomar Holdings ($PLMR) reported earnings yesterday and they were in line with expectations. I took this stock off the Growth Stock List prior to the earnings release because we did not have enough profit in the stock to justify holding it over ear ...
- Robert1965: @DAN $PLMR $CMG $SHAK $MYGN The only except was $IBP up on earnings now down, you can add to your list $TWTR, and $LGIH which also went down on earnings, good lesson DAN only hold if you have a good profit
- efrain007: $MYGN acting well, move over flag continues.
- efrain007: $MYGN broke out of base cpl weeks ago and moving out of flag today
- Cokeman1959: @efrain007 $MYGN Do youfeel like the $50 level from last August and September was too long ago to be relevant now?
- efrain007: @Cokeman1959 $MYGN In my opinion yes, but I don't plan to hold it that long. Assuming my trade works, I'm planning to trim around 200d and then around 40 area as that area was support back in the time frame you mentioned. With that said, anything can happen between now and whenever so my sell plan is subject to change based on what the chart does.
- efrain007: @Cokeman1959 $MYGN Sorry forgot to mention the base... 27-33 is 6 so my target expectation is 39-40 so another reason why I'd let it go around 40.
- issues: Earnings for tomorrow: $TJX $MDT $URBN $KSS $YRD $TUES(very appropriate for reporting on Tues!) $MYGN
- Hank1: $MYGN ... boom
- DAN: @Hank1 $MYGN 8-) Nice. Hope you're in that, Hank.
- JJT1: $MYGN Breaking down. Out of trade 30% loss.
- JJT1: $MYGN One dip into drillers and this is one dip into bio BTO $MYGN Nov 30 calls
- debeers: $MYGN-Nice move on the upgrade.
- magriver: Thanks to all! My initial thoughts were to dump them and hold cash while looking for stocks that showed some promise. Might still do that but I'll look at everyone's suggestions. Right now I have positions in $AIG, $MIME, $NI, $SIX, $SYK, $V, $VEA, and $VO. I have the following on watch list $MYGN, $HCI, $PSTG, $IPHI, $CGNX, and, $JOUT
- humble: $MYGN @DAN love to know your thoughts. Uptrending and working. Specifically the RSI is over 70 (lasting uptrend or overbought).....Just keep an eye on direction? thanks! Anyone thoughts?
- DAN: @humble $MYGN MYGN working. I don't really pay much attention to RSI. If I had a nickle for each time that Josh (downtown) Brown talks about RSI on CNBC, I would be able to retire to my private tropical island. If RSI is above 70, that's the best sign that the trend is strong. At some point, that will change. But I like 70 RSIs.
- humble: @DAN $MYGN Thanks DAN...helps me confirm !
- Bridget: $MYGN flagging here
- JJT1: $MYGN Missed on Friday on entry, forgot to check on Monday, then today I'm constantly reminded by watching it come by my hi/lo ticker on the green side...
- JJT1: $MYGN Looked to be bounce off 50 day SMA on daily. Put order in for Aug 24 calls, never filled, did not chase. See what monday brings.
- JJT1: $MYGN On oversold Buy list. Looks to be coming in for tag of 50 day, printing higher highs and higher lows. np but watching.
-
Bridget: ...
$MYGN - start of a cup and handle
$MO - moving higher after consolidation
$NLY - working
$XL - bouncing
$SQ - flagging, $PYPL also recovering
$TTMI - flagging
$AAOI - at a good buy point
$MDSO - at a good buy point
$CTRL - uptrend intact
$HBD - upt ... - woodman:
- TunaHelper: @debeers Another ticker you may want to consider in women's health is $MYGN. Could be coming out of a squeeze (though BBs aren't necessarily within the 6% threshold, they are pretty tight). Nice short interest. Just came out with info on their breast cancer recurrence prediction/test.
- TunaHelper: @TunaHelper $MYGN It's also crossed through the 3SD BB today.
-
debeers: $HOLX/$MYGN-found superior to Oncotype DX. Again, I think that Women's Health, a lynchpin of the promised agenda will be fine. I just choose to play it with a less sensitive focus: hence $HOLX
Hologic, Inc. is a developer, manufacturer and supplier o ... - woodman: @debeers $HOLX $MYGN I just don't believe for a moment that women's health will be a top agenda item for this Administration regardless of what may or may not have been said. So many other things they want to do.
- Aragorn: @arrow $HOLX $MYGN no was just going to delete it
- greenpatrol: @Aragorn $HOLX $MYGN That is certainly a stretch to believe there will be an emphasis on that. I like the look of the chart of $HOLX though, so I am long.
- Aragorn: @greenpatrol $HOLX $MYGN 41.50 there is a triangle line I have so that is the first target I have yes I agree on both counts
- debeers: @Aragorn $HOLX $MYGN -Just because you deleted, doesn't mean it wasn't read
- Aragorn: @debeers $HOLX $MYGN So I deleted it not because of you but because of the appropriateness of the venue. If you really think what you wrote is real good for you. I do not. The chart is another story that works, and I am not looking to make a political statement here but you seem to have no issue with that
- Aragorn: $MYGN inside day and up but a broken chart , this si just a bounce play no posiiton
- Aragorn: $MYGN reversing off he lows
- Kid2old: @Aragorn $AAL $ADBE $ADRO $ALK $ALNY $AMZN $APA $ASPS $ATI $ATVI $BIB $BIDU $BMY $CA $CAKE $CANF $CBRL $CBS $CEMP $CENX $CMG $COG $COR $CORE $COST $CRM $CSX $CTL $CTRP $CTSH $CVLT $DATA $DIS $DPLO $DRI $DSX $EAT $EBAY $EQIX $EXPE $FBIO $FDX $FOLD $FRSH $FTI $GOOG $GOOGL $GWW $HERO $HLF $IBB $ILMN $INSY $IP $ITB $JBHT $JUNO $KMI $LAKE $LJPC $LL $LNKD $LOCO $LOW $LVLT $LVS $MLNX $MSFT $MXL $MYGN $NDAQ $NDLS $NOC $NTES $NVDA $ONVO $ORCL $PM $QLD $QQQ $R $RAX $RDUS $RENN $RH $RL $RMBS $RWLK $SAVE $SDRL $SGY $SINA $SLCA $SU $SVXY $SWHC $SWN $SYNA $TASR $TDW $TQQQ $TREX $TROV $TSCO $TSLA $UA $ULTI $UTX $UVXY $V $VA $VISN $VIXY $VRX $VXX $WHR $WY $XHB $XIV $XLK $XLY $XOMA $XONE
- SierraJW: @Aragorn Your list w/"$"'s: _ Inside Day and up $AA $AEP $ANF $BEAV $CLF $CNP $CTL $DECK $DSX $FGEN $FIVE $GWRE $HRS $IONS $JUNO $K $KORS $LNKD $MBLY $MYGN $NEE $NTES $PLAY $RDUS $SUNE $SWHC $TAN $VEEV $YOKU $YY Inside day and down - $CZR $DMND $GMCR $MYL $VRTX $XL
- Aragorn: @SierraJW $AA $AEP $ANF $BEAV $CLF $CNP $CTL $DECK $DSX $FGEN $FIVE $GWRE $HRS $IONS $JUNO $K $KORS $LNKD $MBLY $MYGN $NEE $NTES $PLAY $RDUS $SUNE $SWHC $TAN $VEEV $YOKU $YY $CZR $DMND $GMCR $MYL $VRTX $XL Thanks Sierra
- issues: Most profitable 10 Nasdaq biotech companies with the widest net income margins (earnings divided by revenue) over the past 12 reported months. They also must have market values of at least $100 million: $PDLI, $GILD, +0.11% $104.43 $7.38 48.62% Bio-Techne Corp. $TECH, 0.27% $98.69 $3.10 31.01% Biogen Idec Inc. $BIIB, 0.79% $408.94 $12.39 30.27% China Biologic Products Inc. CBPO, -9.96% $71.96 $2.56 26.63% Amgen Inc. $AMGN, -0.74% $158.08 $6.70 25.74% Repligen Corp. $RGEN, 0.14% $25.88 $0.36 23.61% Myriad Genetics Inc. $MYGN, -3.16% $35.42 $1.44 22.64% $CYBX $60.37 $2.33 19.46% http://www.marketwatch.com/story/these-are-the-most-profitable-nasdaq-biotech-companies-2015-02-27?siteid=bigcharts&dist=bigcharts
- issues: The IBD 50 sure changed dramatically this week. There are 25 new stocks replacing 25 from last weeks. The new ones are ones that didn't go down as much (more than going up so much) This shows a very defensive stance the market has taken. Here's the IBD 50 list for today $ABC $AET $AMCX $ANET $CALM $CDW $CELG $CNC $CPB $CRI $CRL $CTXS $DG $DY $ELLI $EPAM $EQM $EW $FL $GGAL $HA $HAWK $HII $ICLR $IDTI $ITC $LGND $LNKD $MYGN $NKE $NTES $NUAN $OLED $PLAY $PRXL $REGN $RHT $ROST $SIG $STE $STZ $SWHC $TDG $TSO $ULTA $VEEV $WBMD $XRS $YY
- Aragorn: @issues $ABC $AET $AMCX $ANET $CALM $CDW $CELG $CNC $CPB $CRI $CRL $CTXS $DG $DY $ELLI $EPAM $EQM $EW $FL $GGAL $HA $HAWK $HII $ICLR $IDTI $ITC $LGND $LNKD $MYGN $NKE $NTES $NUAN $OLED $PLAY $PRXL $REGN $RHT $ROST $SIG $STE $STZ $SWHC $TDG $TSO $ULTA ...
- Aragorn: $MYGN $CERS here are 2 ideas . MYGN breaking out of a flag. CERS moving up the 8ema setting up for a measured move up
- DCorion: @Aragorn $MYGN $CERS I appreciate your many ideas. Also been watching $ABC. Looks to be setting up above the 50 day and trying poke thru the 200 day and in VS.
- Aragorn: @DCorion $MYGN $CERS $ABC I was surprised when this broke below the 50 at the 112 area. I was very positive that this would hold up and even posted about that when someone asked about the stock. I felt the same about $MCK. ABC is rebounding more than MCK. Yes ABC looks good lets see in 5 bucks what happens at the 200 but we have positive MACD and BOP a possible tell on future moves has been positive showing large orders on the buy side 5 dollars ago so maybe institutions are getting behind this. I have no position and thanks for sharing with the forum.
- ogas: @Aragorn $MYGN $CERS How are you calculating your measured move?
- TRICIA: $MYGN - OUCH! Court of Appeals affirms Myriad's $MYGN BRCA patent claims are invalid.
- ginny: $MYGN. 51% shorts
- ginny: $MYGN 51% shorts
- ginny: $MYGN bought a starter. 51% shorts
- issues: $GLOG I'm underwater, glog glog... It's a LT hold but I hate to see a profit go to a loss. I'm holding on. I can't get motivated to buy. I like the turnaroudn with $MYGN. I would like to buy more $MTDR but am hesitating. Anyone else in the "brain freeze" department?
- issues: $MYGN Does anybody (Tricia?) still like $MYGN? I even and thinking of putting i a stop. Any idea where?
- issues: @issues Thank you issues for your question. $MYGN is still good but "declining good," which isn't good. So I would recommend putting your stop in at $31.89. Thank you for your input. GL
- Tricia: $BMY - happy I added this am - made $.80 per share. Day Trades included $SYN, $RNN, &$TGXT .. Tight reins on LT positions .. and more than half cash ... ASCO plays, $BMY, $CLVS, $GILD, $ACAD, $STEM, $MYGN, $RHHBY,and $CLDX. - some are swing trades for ASCO. (Long in BMY, GILD, CLVS, RHHBY,ENTA, and MYGN. Watching Jazz, TSRO, and CLDX Have a great evening
- issues: @Tricia Is $MYGN a LT or trade? We currently hold a small number of shares. Why do you like it? I noticed it had a declining eps qt/at .68 .66 .60 .44. It's got good IBD ratings. I was trying to decide whether or not to add.
- Tricia: $MYGN - has 11 diagnostic tests for ASCO .. in sddition, it boughtCrescendo Bioscience in Feb for $270 million for a proprietary test for patients with rheumatoid arthritis. It’s the first-ever quantifiable way of measuring the molecular activity of this common inflammatory disease. It’s a radical new idea in a world where physicians—even in 2014!—basically just squeeze knuckle joints, ask patients how much it hurts, and then make a subjective judgment on what to do next. This test has the potential to tell a Rhuematologist when a cheap generic drug is holding the disease in check at the molecular level, or when a $20,000 a year biotech drug isn’t getting the job done. It took Crescendo three years on the market before it could get Medicare reimbursement at $575 per test. But once approved, MYGN scooped it up.
- issues: $MTDR beat earnings by 20% but it's down 7%. $MYGN beat by 30% yet it's down 10%. Go figure. Anyway I hold both of these and was thinking of adding to $MYGN... but it's probably better to wait until I see green candles, right? This may be a good time to add to $MTDR ??
- issues: @NapoleonSolo Hey now not so defensive. Sure I appreciate your advice that's why I wrote that $MTDR is not a biotech, to be sure you gave me the right advice. I would say that all of us here on SMM are "learners" otherwise why be part of this educational mentoring, right? Do you think $GILD & $MYGN are biotechs? If I didn't want advice I wouldn't write in. Another loser I have is $SFUN. I have many winners but I cut the losers and let the winners ride. I have $BEAV and Dan said to sell it. So I'm thinking of putting in a stop, where would you suggest?
- Aragorn: @Dan the IBD 50 Bios and devices is a good place to review some of them and they are as follows - $ACT ANIK $ALXN VRX $JAZZ SLXP $BIIB WX $GMED GRFS $MYGN . Some of these are still working and holding up. $ANIK looks interesting symmetrical Triangle but getting tight it needs to do something soon or it will fall and I like that it is holding the 8ema but I want your thoughts so no more Jay Analysis. Also the ones not working where you think we might get support. IBD50's are a good place to always start some research as these are usually trending and MOMO stocks to begin with. Thanks
- issues: $MYGN GMED $WX or $CBM I was trying to decide between these 4. I have a small position in WX. $GMED has negative earnings while $CBM is positive. Anyone know anything about these or hold them?
- Tim S: Notable earnings after Tuesday's close $ACLS, $AEC, $AFL, $AMP, $ATO, $ATW, $AXS, $BWLD, $CBL, $CENT, $CERN, $CHRW, $CODE, $CVD, $DATA, $DV, $EQR, $EXP, $GAS, $GHDX, $GILD, $GIMO, $GNW, $HAIN, $HCSG, HI, $JKHY, $KEYW, $MAC, $MWA, $MX, $MYGN, $NANO, $OCLR, $OMCL, $PACB, $PIKE, $TDW, $THOR, $ULTI, $UNM, $USNA, $VASC, $VOCS, XOOM
- Tricia: MYGN: SWEET!> Myriad flies after beat, raise, and acquisition Molecular diagnostic testing revenue of $196.2M in FQ2 up 39% from a year ago. "We believe that our increased sales, marketing, and education efforts resulted in wider acceptance of our molecular diagnostic tests by the medical community and increased patient testing volumes."Oncology revenue of $101.6M up 12%. Women's health revenue of $94.6M up 90%.Net income of $50.4M up 44% from a year ago.3.2M shares repurchased for $77.8M. FQ2 weighted average share count of 76.8M compares to 84.2M a year ago.FY2014 $EPS outlook is boosted to $2.09-$2.12 from $1.92-$1.97 on revenue of $740M-$750M from $700M-$715M. Earlier: Buying Crescendo Bioscience for $270M. $MYGN +15.5% AH
- moneyHoHo: $MYGN - Someone is buying AH.
- Tricia: MYGN: $CMS reducing BRCA testing reimbursement by 50%. Bad for $MYGN and other single test Dx companies. Good for multi gene panel Dx & Nex gen seq
- Tim S: Notable earnings after Tuesday's close $ACAS, $AGU, $ANV, $APEI, $ASIA, $AXLL, $BCOR, $BLMN, $BMR, $CBL, $CHRW, $CKEC, $CTRP, $CWT, $DEPO, $DOX, $DPM, $DVA, $ENPH, $EOX, $EPR, $ETE, $ETP, $FNGN, $FOSL, $FOXA, $FTR, $FURX, $GEVO, $GHDX, $GIVN, $GPOR, $GTY, $HAIN, $IAG, $IMPV, $ININ, $JAZZ, $JCOM, $JKHY, $KAR, $KND, $LLNW, $LXU, $LYV, $MCEP, $MED, $MELI, $MIDD, $MKTG, $MSPD, $MYGN, $NRP, $NYMT, $OKE, $OKS, $OPEN, $ORA, $PZZA, $QEP, $QUAD, $REGI, $REXX, RGP, $RGR, $SALE, $SAPE, $SD, $SGEN, $SREV, $SSRI, $SSS, $SXL, $SYNC, $SZYM, $TNGO, $TSLA, $TWO, $URS, $VCLK, $VRSK, $VVUS, $WWWW, $Z, ZAGG
-
Tricia: MYGN: The Anjolina Breast Cancer test is threatened by Quest Diagnostics DCX which announced its own BRAC Genetic test for 1/8th cost .....
Not everyone agrees that a race to the bottom is in the works," writes Forbes' Matthew Herper,"MYGN has ... ... - Tim S: Notable earnings after Tuesday's close $BRCD, $CREE, $JDSU, $JKHY, $MM, $MYGN, $PRMW, XONE
- boba: $MYGN - This bio tech took off this am on a Supreme Court ruling on lab created genes. http://www.forbes.com/sites/danielfisher/2013/06/13/supreme-court-rejects-human-gene-patents-sort-of/?partner=yahootix
- boba: $MYGN @bigbartabs - Even if they made you $$ ???
- boba: $MYGN @bigbartabs - I think we would all pay big $$ to see that.
- rczar: $MYGN @bigbartabs....Did You see my picture on Facebook to post about my attire ? One mistake though, the socks are knee high BLACK stretch, not white. New $LULU look !
- mtnman: $MYGN -Like the reversal today. If it can clear 34.70 it has a lot of room. Long common.
- mtnman: $MYGN -Got in this a few days ago on a pullback. It was downgraded today and has not taken a hit - just the opposite. Doesn't @Dan say that it's a tell when a stock doesn't do what it ought to do? I know there is some headline risk with this one based on an upcoming Supreme Court decision on patents but I like their fundamentals and the chart. Does anyone know much about this name or have any insights as to the impact of the court decision? (One of their products was used in diagnosing Angelina Jolie's probability for getting breast cancer).
- mtnman: $MYGN -Buying this lighter volume pullback to the 20 and bounce. Biotechs are hot today.
-
gold2stocks: ...
$MYGN
Myriad Genetics upgraded at Leerink
May 21, 2012 | 8:13 AM EDT
$MYGN was upgraded from Market Perform to Outperform, Leerink Swann said. Reimbursement and IP fears appear overdone.
$NBR
Nabors upgraded at Gug ... -
gold2stocks: ...
$MYGN
Myriad Genetics rated new Neutral at BofA Merrill
$MYGN was initiated with a Neutral rating, Bank of America Merrill Lynch said. $28 price target. Shares appear fairly valued given uncertainties.
PSSI
$PSS World Medical downgraded at ... -
gold2stocks: ...
$MYGN
Myriad Genetics numbers raised at Oppenheimer
Shares of $MYGN now seen reaching $29, Oppenheimer said. Estimates also raised on another solid beat and raise. Perform rating.
$OPEN
OpenTable, Inc. target lowered at Oppenheimer
Shares of ... - aloha808: $MYGN - any biotech fans follow Myriad? Thoughts about the chart? Buy any breakout above $25? The fundamentals seem reasonable. $4/share in cash, no debt and a growing revenue stream.
| Stock Price | $18.49 |
| Change | -0.80% |
| Volume | 622,209 |
Myriad Genetics, Inc., is engaged in the discovery and commercialization of transformative tests which assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.
Request Video of MYGNAlready a member? Sign in here.
Past Month
Leading Peers
-
$62.33 5.19%
-
$47.61 0.84%
-
$125.91 -1.43%
Past Month
Lagging Peers
-
$11.93 -26.82%
-
$28.36 -22.20%
-
$8.07 -21.64%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!